Literature DB >> 6292493

Simple repeat sequence in Epstein-Barr virus DNA is transcribed in latent and productive infections.

M Heller, V van Santen, E Kieff.   

Abstract

The BamHI K region of Epstein-Barr virus DNA is transcribed in latently infected cells from Burkitt tumors and in growth-transformed B-lymphocytes latently infected with Epstein-Barr virus. We determined the nucleotide sequence of a 1,153-base pair HinfI fragment in BamHI fragment K from the B95-8 Epstein-Barr virus isolate. The fragment contains a remarkable 708-base pair simple sequence repeat array, designated IR3, which is composed of only three nucleotide triplet elements: GGG, GCA, and GGA. The triplets are organized into three repeat units: GCAGGA, GCAGGAGGA, and GGGGCAGGA. Immediately 3' of IR3 are tandem nearly perfect direct repeats of two different 24-base pair sequences. IR3 is conserved at a colinear position in the DNAs of other Epstein-Barr virus isolates, and a homologous sequence maps at the same location in the genome of a genetically related baboon herpesvirus, herpesvirus papio. IR3 is transcribed from left to right in latently infected, growth-transformed IB4 cells. It encodes part of a 2.0-kilobase exon of the 3.7-kilobase cytoplasmic polyadenylated RNA previously detected in IB4 cells (van Santen et al., Proc. Natl. Acad. Sci. U.S.A. 78:1930-1934, 1981). IR3 also encodes parts of 2.4- and 1.0-kilobase RNAs in productively infected B95-8 cells.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292493      PMCID: PMC256266     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Proteins of Epstein-Barr virus. I. Analysis of the polypeptides of purified enveloped Epstein-Barr virus.

Authors:  M Dolyniuk; R Pritchett; E Kieff
Journal:  J Virol       Date:  1976-03       Impact factor: 5.103

2.  Evolution of repeated DNA sequences by unequal crossover.

Authors:  G P Smith
Journal:  Science       Date:  1976-02-13       Impact factor: 47.728

3.  Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines.

Authors:  B M Reedman; G Klein
Journal:  Int J Cancer       Date:  1973-05       Impact factor: 7.396

4.  3' non-coding region sequences in eukaryotic messenger RNA.

Authors:  N J Proudfoot; G G Brownlee
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

5.  A simple method for DNA restriction site mapping.

Authors:  H O Smith; M L Birnstiel
Journal:  Nucleic Acids Res       Date:  1976-09       Impact factor: 16.971

6.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

7.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

8.  Immunofluorescence and herpes-type virus particles in the P3HR-1 Burkitt lymphoma cell line.

Authors:  Y Hinuma; M Konn; J Yamaguchi; D J Wudarski; J R Blakeslee; J T Grace
Journal:  J Virol       Date:  1967-10       Impact factor: 5.103

9.  Properties of a baboon lymphotropic herpesvirus related to Epstein-Barr virus.

Authors:  L Falk; F Deinhardt; M Nonoyama; L G Wolfe; C Bergholz
Journal:  Int J Cancer       Date:  1976-12-15       Impact factor: 7.396

10.  Antigens and DNA of a chimpanzee agent related to Epstein-Barr virus.

Authors:  P Gerber; R F Pritchett; E D Kieff
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103

View more
  39 in total

1.  Simple sequence repeats in mycobacterial genomes.

Authors:  Vattipally B Sreenu; Pankaj Kumar; Javaregowda Nagaraju; Hampapathalu A Nagarajam
Journal:  J Biosci       Date:  2007-01       Impact factor: 1.826

2.  Levels of Epstein-Barr virus DNA in lymphoblastoid cell lines are correlated with frequencies of spontaneous lytic growth but not with levels of expression of EBNA-1, EBNA-2, or latent membrane protein.

Authors:  S Metzenberg
Journal:  J Virol       Date:  1990-01       Impact factor: 5.103

3.  Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells.

Authors:  L T Wen; A Tanaka; M Nonoyama
Journal:  J Virol       Date:  1989-08       Impact factor: 5.103

4.  A promoter for the highly spliced EBNA family of RNAs of Epstein-Barr virus.

Authors:  M Bodescot; M Perricaudet; P J Farrell
Journal:  J Virol       Date:  1987-11       Impact factor: 5.103

5.  Repeat arrays in cellular DNA related to the Epstein-Barr virus IR3 repeat.

Authors:  M Heller; E Flemington; E Kieff; P Deininger
Journal:  Mol Cell Biol       Date:  1985-03       Impact factor: 4.272

6.  Latent and viral replicative transcription in vivo from the BamHI K fragment of Epstein-Barr virus DNA.

Authors:  R Weigel; G Miller
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

7.  Short repeats cause heterogeneity at genomic terminus of bovine herpesvirus 1.

Authors:  W Hammerschmidt; H Ludwig; H J Buhk
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

8.  Molecular characterization and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene.

Authors:  C J Danpure; G M Birdsey; G Rumsby; M J Lumb; P E Purdue; J Allsop
Journal:  Hum Genet       Date:  1994-07       Impact factor: 4.132

9.  Identification of Epstein-Barr nuclear antigen polypeptide in mouse and monkey cells after gene transfer with a cloned 2.9-kilobase-pair subfragment of the genome.

Authors:  D K Fischer; M F Robert; D Shedd; W P Summers; J E Robinson; J Wolak; J E Stefano; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

10.  Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.

Authors:  S Fennewald; V van Santen; E Kieff
Journal:  J Virol       Date:  1984-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.